依赖MYC的lncRNA MB3通过通过HMGN5调节TGF-β通路来抑制第三组中枢细胞瘤中细胞灭亡
Alessia Grandioso1,2, Paolo Tollis3, Francesca Romana Pellegrini2
1Department of Biology and Biotechnologies Charles Darwin, Sapienza University of Rome, Rome, Italy.
Cell death & disease
|November 6, 2025
概括
一种新型的长非编码RNA, lncMB3,通过抑制亡来驱动侵袭性的儿科髓母细胞瘤 (MB). 针对 lncMB3 为这种具有挑战性的脑瘤提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 第三组髓母细胞瘤 (G3 MB) 是一种侵袭性的儿科脑瘤,通常是由MYC瘤基因驱动的.
- 准MYC和理解G3 MB分子驱动因素仍然是重要的治疗挑战.
- 长非编码RNAs (lncRNAs) 具有作为新的治疗点和生物见解的潜力.
研究的目的:
- 在G3 MB中阐明MYC依赖的lncRNA,IncMB3的功能和机制.
- 通过探索 lncMB3.3 的作用来确定 G3 MB 的新疗法策略.
- 调查涉及IncMB3,MYC和G3 MB的细胞亡的监管网络.
主要方法:
- 利用多组学方法和分子/细胞试验来研究 lncMB3.3.
- 研究了lncMB3与TGF-β通路和HMGN5mRNA的相互作用.
- 评估了 lncMB3 向对细胞亡和 G3 MB 驱动器 (如 OTX2.2) 的影响.
- 开发并提出基于费里的纳米载体用于反感性寡核酸递送.
主要成果:
- 鉴定了IncMB3作为一个MYC依赖的,对G3MB至关重要的抗丧性IncRNA.
- 证明IncMB3通过抑制HMGN5mRNA翻译来调节TGF-β通路.
- 显示IncMB3通过光受体系基因影响细胞亡,包括OTX2.2.
- 观察到IncMB3向和西斯治疗之间的协同效应.
结论:
- lncMB3通过基于RNA的机制将MYC放大与G3 MB中的亡抑制联系在一起.
- 针对IncMB3,可能使用新的纳米载体传递系统,代表了一个有前途的治疗途径.
- 这项研究加深了对G3MB病原学的理解,并突出了lncRNA研究的翻译潜力.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K


